Skip to main content

Advertisement

SpringerLink
Log in

Management of incidental adrenal masses: an update

  • Special Section: Adrenal disease
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 26 May 2020

Abstract

Objective

To review the current evidence and guidelines for diagnosis and management of incidental adrenal masses with a focus on the recent changes made by the American College of Radiology (ACR) Incidental Findings Committee.

Conclusion

Incidentally detected adrenal nodules are a commonly encountered finding estimated to occur in 5–7% of the adult population. By following current recommendations, radiologists can improve patient care by efficiently determining which masses require further diagnostic testing and which masses can be considered benign and not require further follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Reproduced with permission from Mayo-Smith et al. [6]

Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Young WF. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med. 2007;356(6):601-10.

    Article  CAS  Google Scholar 

  2. Schieda N, Siegelman ES. Update on CT and MRI of Adrenal Nodules. AJR Am J Roentgenol. 2017;208(6):1206-17.

    Article  Google Scholar 

  3. Grossman A, Koren R, Tirosh A, Michowiz R, Shohat Z, Rahamimov R, et al. Prevalence and clinical characteristics of adrenal incidentalomas in potential kidney donors. Endocr Res. 2016;41(2):98-102.

    Article  Google Scholar 

  4. Boland GW, Blake MA, Hahn PF, Mayo-Smith WW. Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. Radiology. 2008;249(3):756-75.

    Article  Google Scholar 

  5. Song JH, Chaudhry FS, Mayo-Smith WW. The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol. 2008;190(5):1163-8.

    Article  Google Scholar 

  6. Mayo-Smith WW, Song JH, Boland GL, Francis IR, Israel GM, Mazzaglia PJ, et al. Management of Incidental Adrenal Masses: A White Paper of the ACR Incidental Findings Committee. J Am Coll Radiol. 2017;14(8):1038-44.

    Article  Google Scholar 

  7. Boland GW, Goldberg MA, Lee MJ, Mayo-Smith WW, Dixon J, McNicholas MM, et al. Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-d-glucose. Radiology. 1995;194(1):131-4.

    Article  CAS  Google Scholar 

  8. Berland LL, Silverman SG, Gore RM, Mayo-Smith WW, Megibow AJ, Yee J, et al. Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol. 2010;7(10):754-73.

    Article  Google Scholar 

  9. Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM, Mueller PR. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol. 1998;171(1):201-4.

    Article  CAS  Google Scholar 

  10. Caoili EM, Korobkin M, Francis IR, Cohan RH, Platt JF, Dunnick NR, et al. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology. 2002;222(3):629-33.

    Article  Google Scholar 

  11. Wortman JR, Bunch PM, Fulwadhva UP, Bonci GA, Sodickson AD. Dual-Energy CT of Incidental Findings in the Abdomen: Can We Reduce the Need for Follow-Up Imaging? AJR Am J Roentgenol. 2016;207(4):W58-W68.

    Article  Google Scholar 

  12. Ho LM, Marin D, Neville AM, Barnhart HX, Gupta RT, Paulson EK, et al. Characterization of adrenal nodules with dual-energy CT: can virtual unenhanced attenuation values replace true unenhanced attenuation values? AJR Am J Roentgenol. 2012;198(4):840-5.

    Article  Google Scholar 

  13. Gnannt R, Fischer M, Goetti R, Karlo C, Leschka S, Alkadhi H. Dual-energy CT for characterization of the incidental adrenal mass: preliminary observations. AJR Am J Roentgenol. 2012;198(1):138-44.

    Article  Google Scholar 

  14. Connolly MJ, McInnes MDF, El-Khodary M, McGrath TA, Schieda N. Diagnostic accuracy of virtual non-contrast enhanced dual-energy CT for diagnosis of adrenal adenoma: A systematic review and meta-analysis. Eur Radiol. 2017;27(10):4324-35.

    Article  Google Scholar 

  15. Glazer DI, Maturen KE, Kaza RK, Francis IR, Keshavarzi NR, Parker RA, et al. Adrenal Incidentaloma triage with single-source (fast-kilovoltage switch) dual-energy CT. AJR Am J Roentgenol. 2014;203(2):329-35.

    Article  Google Scholar 

  16. Morgan DE, Weber AC, Lockhart ME, Weber TM, Fineberg NS, Berland LL. Differentiation of high lipid content from low lipid content adrenal lesions using single-source rapid kilovolt (peak)-switching dual-energy multidetector CT. J Comput Assist Tomogr. 2013;37(6):937-43.

    Article  Google Scholar 

  17. Mileto A, Nelson RC, Marin D, Roy Choudhury K, Ho LM. Dual-energy multidetector CT for the characterization of incidental adrenal nodules: diagnostic performance of contrast-enhanced material density analysis. Radiology. 2015;274(2):445-54.

    Article  Google Scholar 

  18. Kaza RK, Raff EA, Davenport MS, Khalatbari S. Variability of CT Attenuation Measurements in Virtual Unenhanced Images Generated Using Multimaterial Decomposition from Fast Kilovoltage-switching Dual-energy CT. Acad Radiol. 2017;24(3):365-72.

    Article  Google Scholar 

  19. Wortman JR, Sodickson AD. Pearls, Pitfalls, and Problems in Dual-Energy Computed Tomography Imaging of the Body. Radiol Clin North Am. 2018;56(4):625-40.

    Article  Google Scholar 

  20. Kim YK, Park BK, Kim CK, Park SY. Adenoma characterization: adrenal protocol with dual-energy CT. Radiology. 2013;267(1):155-63.

    Article  Google Scholar 

  21. Adam SZ, Nikolaidis P, Horowitz JM, Gabriel H, Hammond NA, Patel T, et al. Chemical Shift MR Imaging of the Adrenal Gland: Principles, Pitfalls, and Applications. Radiographics. 2016;36(2):414-32.

    Article  Google Scholar 

  22. Mayo-Smith WW, Lee MJ, McNicholas MM, Hahn PF, Boland GW, Saini S. Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures. AJR Am J Roentgenol. 1995;165(1):91-5.

    Article  CAS  Google Scholar 

  23. Haider MA, Ghai S, Jhaveri K, Lockwood G. Chemical shift MR imaging of hyperattenuating (> 10 HU) adrenal masses: does it still have a role? Radiology. 2004;231(3):711-6.

    Article  Google Scholar 

  24. Seo JM, Park BK, Park SY, Kim CK. Characterization of lipid-poor adrenal adenoma: chemical-shift MRI and washout CT. AJR Am J Roentgenol. 2014;2002(5):1043-50.

    Article  Google Scholar 

  25. Boland GW, Dwamena BA, Jagtiani Sangwaiya M, Goehler AG, Blake MA, Hahn PF, et al. Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology. 2011;259(1):117-26.

    Article  Google Scholar 

  26. Hahner S, Sundin A. Metomidate-based imaging of adrenal masses. Horm Cancer. 2011;2(6):348-53.

    Article  CAS  Google Scholar 

  27. Song JH, Grand DJ, Beland MD, Chang KJ, Machan JT, Mayo-Smith WW. Morphologic features of 211 adrenal masses at initial contrast-enhanced CT: can we differentiate benign from malignant lesions using imaging features alone? AJR Am J Roentgenol. 2013;201(6):1248-53.

    Article  Google Scholar 

  28. Ozsari L, Kutahyalioglu M, Elsayes KM, Vicens RA, Sircar K, Jazaerly T, et al. Preexisting adrenal masses in patients with adrenocortical carcinoma: clinical and radiological factors contributing to delayed diagnosis. Endocrine. 2016;51(2):351-9.

    Article  Google Scholar 

  29. Nogueira TM, Lirov R, Caoili EM, Lerario AM, Miller BS, Fragoso MC, et al. Radiographic Characteristics of Adrenal Masses Preceding the Diagnosis of Adrenocortical Cancer. Horm Cancer. 2015;6(4):176-81.

    Article  CAS  Google Scholar 

  30. Zeiger MA, Thompson GB, Duh QY, Hamrahian AH, Angelos P, Elaraj D, et al. The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract. 2009;15 Suppl 1:1-20.

    Article  Google Scholar 

  31. Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, et al. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2016;175(2):G1-G34.

    Article  CAS  Google Scholar 

  32. Chomsky-Higgins K, Seib C, Rochefort H, Gosnell J, Shen WT, Kahn JG, et al. Less is more: cost-effectiveness analysis of surveillance strategies for small, nonfunctional, radiographically benign adrenal incidentalomas. Surgery. 2018;163(1):197-204.

    Article  Google Scholar 

  33. Dwamena BA, Kloos RT, Fendrick AM, Gross MD, Francis IR, Korobkin MT, et al. Diagnostic evaluation of the adrenal incidentaloma: decision and cost-effectiveness analyses. J Nucl Med. 1998;39(4):707-12.

  34. Patel J, Davenport MS, Cohan RH, Caoili EM. Can established CT attenuation and washout criteria for adrenal adenoma accurately exclude pheochromocytoma? AJR Am J Roentgenol. 2013;201(1):122-7.

    Article  Google Scholar 

  35. Sydow BD, Rosen MA, Siegelman ES. Intracellular lipid within metastatic hepatocellular carcinoma of the adrenal gland: a potential diagnostic pitfall of chemical shift imaging of the adrenal gland. AJR Am J Roentgenol. 2006;187(5):W550-1.

    Article  Google Scholar 

  36. Schieda N, Krishna S, McInnes MDF, Moosavi B, Alrashed A, Moreland R, et al. Utility of MRI to Differentiate Clear Cell Renal Cell Carcinoma Adrenal Metastases From Adrenal Adenomas. AJR Am J Roentgenol. 2017;2009(3):W152-W9.

    Article  Google Scholar 

  37. Dong A, Cui Y, Wang Y, Zuo C, Bai Y. (18)F-FDG PET/CT of adrenal lesions. AJR Am J Roentgenol. 2014;203(2):245-52.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Abdominal Imaging and Intervention, Department of Radiology, Harvard Medical School, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA, 02115, USA

    Daniel I. Glazer

  2. Division of Abdominal Imaging and Intervention, Department of Radiology, Harvard Medical School, Brigham and Women’s Hospital, 1620 Tremont Street, Boston, MA, 02120, USA

    William W. Mayo-Smith

Authors
  1. Daniel I. Glazer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William W. Mayo-Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the conception/design of the work, participated in drafting and editing the manuscript, approved the final version, and are accountable for the manuscript contents.

Corresponding author

Correspondence to Daniel I. Glazer.

Ethics declarations

Disclosures

William W. Mayo-Smith: Book royalties from Elsevier Publishers and Cambridge University Press. Daniel I. Glazer has no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Glazer, D.I., Mayo-Smith, W.W. Management of incidental adrenal masses: an update. Abdom Radiol 45, 892–900 (2020). https://doi.org/10.1007/s00261-019-02149-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-019-02149-2

Keyword

Search

Navigation